Stockscreener 앱 받기
0.74
3.90%
-0.03
Gri Bio Inc 주식(GRI)의 최신 뉴스
GRI Bio (NASDAQ:GRI) Now Covered by HC Wainwright - Defense World
GRI Bio Inc (NASDAQ: GRI): What’s Next After The Stock Plunge? - Stocks Register
Astera Labs Inc: Is ALAB Stock Worth Buying? - Stocks Register
HC Wainwright & Co. Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN
GRI Bio to Participate in the Virtual Investor Closing Bell Series - GlobeNewswire
GRI Bio to Present Corporate Strategy at Virtual Investor Closing Bell Series - StockTitan
GRI Bio reports progress in IPF treatment with GRI-0621 - Investing.com India
GRI Bio Showcases GRI-0621’s Potential to Reduce - GlobeNewswire
GRI Bio's IPF Drug Shows Promise in Preclinical Data, Phase 2a Trial Underway | GRI Stock News - StockTitan
GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) - The Manila Times
GRI Bio files to sell 1.58M shares of common stock for holders - MSN
SEC Form 424B3 filed by GRI Bio Inc. - Quantisnow
GRI Bio Inc (GRI) Quarterly 10-Q Report - Quartzy
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis - GlobeNewswire
GRI Bio Raises $13.9M, Extends Runway for Key IPF Drug Trial Data in 2025 | GRI Stock News - StockTitan
GRI Bio Inc expected to post a loss of 73 cents a shareEarnings Preview - XM
Ascendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy Recommendation - MSN
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com
Primary Sclerosing Cholangitis Pipeline 2024: Clinical Trials - openPR
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio secures funding to advance IPF treatment into 2025 - Investing.com India
GRI Bio secures funding to advance IPF treatment into 2025 By Investing.com - Investing.com UK
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio Announces Exercise of Warrants - GlobeNewswire
Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com
Top Innovation Stocks Surge: PRSO, SYTA, SAVE, ISPC, GRI, BIVIMust-Watch Stocks This Week - openPR
Energy storage ‘key’ to sustainability – report - Yahoo! Voices
As iPhone Sales Soar in China, Is It Time to Buy Apple Stock? - Yahoo! Voices
2 Artificial Intelligence (AI) Stocks That Are No-Brainer Buys - Yahoo! Voices
Statkraft seeks approval for 2.1GW offshore wind farm in Baltic Sea - Yahoo! Voices
BioPorto A/S Announces Changes to the US Commercial Organization - Yahoo Finance
CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - Yahoo Finance
Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitis - Yahoo! Voices
Amcor reports 9% drop in greenhouse gas emissions in 2024 - Yahoo! Voices
Esso Australia completes Kipper Compression Project - Yahoo! Voices
Final countdown: 7 days until TechCrunch Disrupt 2024 kicks off - Yahoo! Voices
Cigna and Humana re-engage in merger talks - Yahoo! Voices
Starr Insurance to operate in Seoul, South Korea - Yahoo! Voices
Alliance Group gets insurance intermediary licence in Germany - Yahoo! Voices
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Live Oak Ventures Participates in Financing of Synply, Inc. - Yahoo Finance
US Stocks Edge Lower; Dow Falls 50 Points - Benzinga
T-Mobile partnership has this beaten down stock launching 🚀 - RagingBull
2 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - Yahoo! Voices
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? - Yahoo Finance
Company News for Oct 21, 2024 - Yahoo Finance
Stock market today: Nasdaq leads stocks lower in wait for earnings to rush in, 10-yr yield climbs to July high - Yahoo
Harris raises more than $220 million in September, outraising Trump 3-to-1 - Yahoo! Voices
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - Yahoo Finance
3 Artificial Intelligence Stocks No One Is Talking About but They Should Be - Yahoo! Voices
JOB ALERT: Goodwill Industries of East Texas needs a supervisor in their south Tyler store - Yahoo News
Is Microsoft Going to $505? 1 Wall Street Analyst Thinks So - Yahoo! Voices
Netflix's Third-Quarter Results Exceeded Expectations. But Is the Stock a Buy? - Yahoo! Voices
Edesa Biotech Announces Upcoming Conference Schedule - Yahoo Finance
This Was the Average Social Security Benefit in 1984, and Here's What It Is Now - Yahoo! Voices
Dynex Capital, Inc. Declares Common Stock Dividends - Yahoo Finance
Fuzzy’s Taco Shop announces new leadership roles - Yahoo! Voices
Saudi Aramco head Amin Nasser positive on China’s continuing oil demand - Yahoo! Voices
FibroBiologics and Charles River link for chronic disease therapies manufacture - Yahoo News
Petrobras to supply Vale with diesel containing renewable content - Yahoo! Voices
SB Energy’s Orion Solar Belt begins commercial operations in US - Yahoo! Voices
FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy - Yahoo! Voices
JDE Peet’s hires ex-Kraft Heinz exec to lead coffee group - Yahoo! Voices
2.88%
2.65%
자본화:
|
볼륨(24시간):